Author

Michael Greene

Observed names: Greene, Michael, M. Greene

Institutions: University of British Columbia, St. Paul's Hospital

Observed institutions: University of British Columbia, University of Ottawa, St. Paul's Hospital, Ottawa Heart Institute

ORCID: 0000-0002-5214-2751

Observed ORCID: 0000-0002-5214-2751

OpenAlex ID: A5064526796

Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation

1996 · C. Kerr, J. Boone, et al. · European Heart Journal · 108

In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues

2006 · Miran Kenk, Michael Greene, et al. · Nuclear Medicine and Biology · 21

Use of a column-switching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[11C]rolipram and their labeled metabolites to the phosphodiesterase-4 enzyme in rat plasma and tissues

2008 · Miran Kenk, Michael Greene, et al. · Nuclear Medicine and Biology · 20

Reduced in vivo phosphodiesterase-4 response to acute noradrenaline challenge in diet-induced obese rats

2009 · Michael Greene, James T. Thackeray, et al. · Canadian Journal of Physiology and Pharmacology · 10

Atrial fibrillation as a precursor of mRNA-1273 SARS-CoV-2 vaccine-induced pericarditis

2022 · Frank X. Scheuermeyer, Jeff Yoo, et al. · Canadian Journal of Emergency Medicine · 4

Binding of phosphodiesterase-4 inhibitor (R)-[carbon-11]rolipram in obese and diabetic rats: Effect of diet and noradrenergic modulation

2006 · Greene, Michael · uO Research (University of Ottawa)

Works count: 6

Citation count: 163

H-index: 4

I10-index: 4